Pledger W J, Stiles C D, Antoniades H N, Scher C D
Proc Natl Acad Sci U S A. 1978 Jun;75(6):2839-43. doi: 10.1073/pnas.75.6.2839.
An ordered sequence of events must be completed before cells become committed to synthesize DNA. A platelet-derived growth factor (PDGF), present in heated (100 degrees ) extracts of human platelets, induces density-inhibited BALB/c-3T3 cells to become competent to proliferate. Platelet-poor plasma induces these competent cells to leave the competence point, progress through G(0)/G(1), and enter the S phase. Treatment of G(0)-arrested, incompetent cells with plasma, before the addition of PDGF, did not shorten the latent period for DNA synthesis or increase the rate of entry into the S phase. Growth arrest points in the plasma-dependent progression sequence were detected in G(0)/G(1). PDGF-treated competent cells were exposed to an optimal concentration of plasma (5%) for various lengths of time and were then transferred to medium lacking plasma; the subsequent readdition of plasma stimulated the cells to enter the S phase. The lag period until DNA synthesis, in such experiments, was dictated by the length of the initial exposure to plasma. PDGF-treated competent cells that were incubated with plasma for 5 hr during the initial exposure did not leave the competence point; they began DNA synthesis 12 hr after the readdition of plasma. However, a population of cells treated with plasma for 10 hr became arrested at a point 6 hr before DNA synthesis, whereas a population treated with plasma for 12-15 hr became arrested at a point immediately before DNA synthesis. Cells remained arrested at this latter point for as long as 24 hr, and these arrested cells were not committed to DNA synthesis. The addition of plasma induced immediate entry into the S phase with an apparent first-order rate of entry being determined by the plasma concentration. This plasma-dependent commitment (transition) to DNA synthesis was blocked by cycloheximide but not by hydroxyurea. Removal of the hydroxyurea allowed cells to enter the S phase synchronously in the absence of plasma.
在细胞开始合成DNA之前,必须完成一系列有序的事件。存在于加热(100摄氏度)的人血小板提取物中的血小板衍生生长因子(PDGF),可诱导密度抑制的BALB/c - 3T3细胞具备增殖能力。血小板贫浆可诱导这些具备能力的细胞离开能力点,经过G(0)/G(1)期,进入S期。在添加PDGF之前,用血浆处理处于G(0)期停滞、无增殖能力的细胞,并不会缩短DNA合成的潜伏期,也不会提高进入S期的速率。在血浆依赖的进展序列中的生长停滞点在G(0)/G(1)期被检测到。用PDGF处理过的具备能力的细胞在不同时长内暴露于最佳浓度(5%)的血浆中,然后转移至不含血浆的培养基中;随后重新添加血浆会刺激细胞进入S期。在这类实验中,直到DNA合成的延迟期由最初暴露于血浆的时长决定。最初暴露时与血浆孵育5小时的用PDGF处理过的具备能力的细胞并未离开能力点;在重新添加血浆后12小时开始DNA合成。然而,用血浆处理10小时的一群细胞在DNA合成前6小时停滞在某一点,而用血浆处理12 - 15小时的一群细胞在DNA合成前即刻停滞在某一点。细胞在这后一点停滞长达24小时,且这些停滞的细胞并未开始DNA合成。添加血浆会诱导细胞立即进入S期,进入的表观一级速率由血浆浓度决定。这种对DNA合成的血浆依赖的转变(过渡)被环己酰亚胺阻断,但未被羟基脲阻断。去除羟基脲可使细胞在无血浆的情况下同步进入S期。